Dear friends of MVMD, I hope this message finds you well. As we approach the end of March and our 2023 fiscal year, I wanted to take a moment to provide a brief update on our company’s progress.
As many of you know from our communications late last year, MVMD has crossed an exciting milestone as we transition from an R&D-focused biotech start-up business into a commercially focused biotech entity.
The team has been working hard on our three core lines of business, which include novel innovations that improve the administration and efficacy of nutraceutical health and wellness products, an agricultural plant signaling technology that organically drives increases in crop yields and supports the reduction of fertilizer usage, and the application of solubilized drugs to positively impact the health of husbandry animals and aquatic species.
Our 2024 fiscal year starts on April 1st and I am personally very excited about the positive advancements our business will make this year as we continue to realize our mission of More Life and positive outcomes that impact human, plant and animal health.
You can learn more about our progress in this short video update here.
Thank you for your continued support of our work.
President & CEO, Mountain Valley MD